Renaissance Technologies’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.9M | Buy |
3,019,871
+552,806
| +22% | +$2.78M | 0.02% | 883 |
|
|
2025
Q4 | $16.7M | Buy |
2,467,065
+458,838
| +23% | +$3.22M | 0.03% | 689 |
|
|
2025
Q3 | $14M | Sell |
2,008,227
-99,550
| -5% | -$692K | 0.02% | 906 |
|
|
2025
Q2 | $12.9M | Buy |
2,107,777
+177,500
| +9% | +$1.18M | 0.02% | 920 |
|
|
2025
Q1 | $14.7M | Buy |
1,930,277
+125,720
| +7% | +$1.05M | 0.02% | 812 |
|
|
2024
Q4 | $17.4M | Buy |
1,804,557
+280,327
| +18% | +$2.18M | 0.03% | 734 |
|
|
2024
Q3 | $9.01M | Sell |
1,524,230
-46,355
| -3% | -$307K | 0.01% | 1089 |
|
|
2024
Q2 | $10.9M | Sell |
1,570,585
-186,000
| -11% | -$1.31M | 0.02% | 874 |
|
|
2024
Q1 | $13.5M | Buy |
1,756,585
+504,800
| +40% | +$4.06M | 0.02% | 836 |
|
|
2023
Q4 | $11M | Buy |
1,251,785
+168,700
| +16% | +$1.24M | 0.02% | 901 |
|
|
2023
Q3 | $7.9M | Buy |
1,083,085
+182,700
| +20% | +$1.36M | 0.01% | 1058 |
|
|
2023
Q2 | $5.95M | Buy |
900,385
+20,800
| +2% | +$106K | 0.01% | 1328 |
|
|
2023
Q1 | $3M | Buy |
879,585
+288,900
| +49% | +$1.12M | ﹤0.01% | 1775 |
|
|
2022
Q4 | $1.64M | Buy |
590,685
+34,300
| +6% | +$103K | ﹤0.01% | 2200 |
|
|
2022
Q3 | $1.6M | Sell |
556,385
-83,676
| -13% | -$297K | ﹤0.01% | 2183 |
|
|
2022
Q2 | $2.22M | Buy |
640,061
+327,676
| +105% | +$1.28M | ﹤0.01% | 2109 |
|
|
2022
Q1 | $1.47M | Buy |
312,385
+134,085
| +75% | +$656K | ﹤0.01% | 2451 |
|
|
2021
Q4 | $1.08M | Buy |
178,300
+63,700
| +56% | +$442K | ﹤0.01% | 2585 |
|
|
2021
Q3 | $694K | Sell |
114,600
-20,000
| -15% | -$225K | ﹤0.01% | 2739 |
|
|
2021
Q2 | $1.68M | Buy |
134,600
+52,000
| +63% | +$563K | ﹤0.01% | 2375 |
|
|
2021
Q1 | $851K | Buy |
82,600
+33,900
| +70% | +$328K | ﹤0.01% | 2675 |
|
|
2020
Q4 | $442K | Buy |
+48,700
| New | +$351K | ﹤0.01% | 2871 |
|
|
2018
Q1 | – | Sell |
-550,500
| Closed | -$6.94M | – | 3488 |
|
|
2017
Q4 | $6.94M | Buy |
550,500
+23,400
| +4% | +$285K | 0.01% | 1605 |
|
|
2017
Q3 | $6.26M | Buy |
527,100
+40,700
| +8% | +$604K | 0.01% | 1621 |
|
|
2017
Q2 | $7.28M | Buy |
+486,400
| New | +$6.49M | 0.01% | 1461 |
|
|
2016
Q2 | – | Sell |
-85,500
| Closed | -$747K | – | 3441 |
|
|
2016
Q1 | $747K | Buy |
85,500
+65,900
| +336% | +$548K | ﹤0.01% | 2713 |
|
|
2015
Q4 | $184K | Buy |
+19,600
| New | +$170K | ﹤0.01% | 3016 |
|
|
2015
Q3 | – | Sell |
-581,500
| Closed | -$6.74M | – | 3280 |
|
|
2015
Q2 | $6.74M | Buy |
581,500
+407,100
| +233% | +$4.19M | 0.02% | 1228 |
|
|
2015
Q1 | $1.81M | Sell |
174,400
-23,772
| -12% | -$222K | ﹤0.01% | 1984 |
|
|
2014
Q4 | $2.29M | Sell |
198,172
-52,828
| -21% | -$522K | 0.01% | 1726 |
|
|
2014
Q3 | $1.79M | Buy |
251,000
+71,100
| +40% | +$496K | ﹤0.01% | 1730 |
|
|
2014
Q2 | $1.27M | Buy |
+179,900
| New | +$1.05M | ﹤0.01% | 1958 |
|
|
2014
Q1 | – | Sell |
-100,350
| Closed | -$877K | – | 2943 |
|
|
2013
Q4 | $877K | Buy |
+100,350
| New | +$614K | ﹤0.01% | 2137 |
|
Other funds holding MDXG
EWM
TI
VCM
PCMI
NCM
FLAM
Renaissance Technologies's MDXG Position: Q1 2026 in Review
Renaissance Technologies increased its MiMedx Group (MDXG) stake by 22% in Q1 2026, buying an estimated $2.78M and bringing the position to 3,019,871 shares worth $11.9M. The position accounts for 0.02% of the portfolio, ranked #883.
Renaissance Technologies first reported a position in MDXG in Q4 2013 and has held it in 33 quarters since. The position peaked at $17.4M in Q4 2024. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.
- Renaissance Technologies held 3,019,871 shares of MiMedx Group worth $11.9M as of Q1 2026.
- Renaissance Technologies bought 552,806 MiMedx Group shares in Q1 2026, an estimated $2.78M.
- MiMedx Group made up 0.02% of Renaissance Technologies's portfolio in Q1 2026, its #883 holding.
- Renaissance Technologies first reported a position in MiMedx Group in Q4 2013 and has held it in 33 quarters since.
- Renaissance Technologies's MiMedx Group position peaked at $17.4M in Q4 2024.
- 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.